Skip to main content
PMC home page
Molecular Medicine logoLink to Molecular Medicine
. 1998 Sep;4(9):557–591. doi: 10.1007/BF03401758

Nitric oxide production and nitric oxide synthase type 2 expression by human mononuclear phagocytes: a review.

J B Weinberg 1
PMCID: PMC2230318  PMID: 9848075

Full text

PDF
557

Images in this article

558Fig. 1
on p.558
572Fig. 4
on p.572
582Fig. 5
on p.582
583Fig. 6
on p.583

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albina J. E. On the expression of nitric oxide synthase by human macrophages. Why no NO? J Leukoc Biol. 1995 Dec;58(6):643–649. doi: 10.1002/jlb.58.6.643. [DOI] [PubMed] [Google Scholar]
  2. Ambs S., Merriam W. G., Bennett W. P., Felley-Bosco E., Ogunfusika M. O., Oser S. M., Klein S., Shields P. G., Billiar T. R., Harris C. C. Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression. Cancer Res. 1998 Jan 15;58(2):334–341. [PubMed] [Google Scholar]
  3. Amin A. R., Attur M., Vyas P., Leszczynska-Piziak J., Levartovsky D., Rediske J., Clancy R. M., Vora K. A., Abramson S. B. Expression of nitric oxide synthase in human peripheral blood mononuclear cells and neutrophils. J Inflamm. 1995;47(4):190–205. [PubMed] [Google Scholar]
  4. Anstey N. M., Weinberg J. B., Hassanali M. Y., Mwaikambo E. D., Manyenga D., Misukonis M. A., Arnelle D. R., Hollis D., McDonald M. I., Granger D. L. Nitric oxide in Tanzanian children with malaria: inverse relationship between malaria severity and nitric oxide production/nitric oxide synthase type 2 expression. J Exp Med. 1996 Aug 1;184(2):557–567. doi: 10.1084/jem.184.2.557. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Assreuy J., Cunha F. Q., Liew F. Y., Moncada S. Feedback inhibition of nitric oxide synthase activity by nitric oxide. Br J Pharmacol. 1993 Mar;108(3):833–837. doi: 10.1111/j.1476-5381.1993.tb12886.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Aubry J. P., Dugas N., Lecoanet-Henchoz S., Ouaaz F., Zhao H., Delfraissy J. F., Graber P., Kolb J. P., Dugas B., Bonnefoy J. Y. The 25-kDa soluble CD23 activates type III constitutive nitric oxide-synthase activity via CD11b and CD11c expressed by human monocytes. J Immunol. 1997 Jul 15;159(2):614–622. [PubMed] [Google Scholar]
  7. Aymerich M. S., Bengoechea-Alonso M. T., López-Zabalza M. J., Santiago E., López-Moratalla N. Inducible nitric oxide synthase (iNOS) expression in human monocytes triggered by beta-endorphin through an increase in cAMP. Biochem Biophys Res Commun. 1998 Apr 28;245(3):717–721. doi: 10.1006/bbrc.1998.8127. [DOI] [PubMed] [Google Scholar]
  8. Bagasra O., Bobroski L., Sarker A., Bagasra A., Saikumari P., Pomerantz R. J. Absence of the inducible form of nitric oxide synthase in the brains of patients with the acquired immunodeficiency syndrome. J Neurovirol. 1997 Apr;3(2):153–167. doi: 10.3109/13550289709015805. [DOI] [PubMed] [Google Scholar]
  9. Bagasra O., Michaels F. H., Zheng Y. M., Bobroski L. E., Spitsin S. V., Fu Z. F., Tawadros R., Koprowski H. Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis. Proc Natl Acad Sci U S A. 1995 Dec 19;92(26):12041–12045. doi: 10.1073/pnas.92.26.12041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Barnewall R. E., Rikihisa Y. Abrogation of gamma interferon-induced inhibition of Ehrlichia chaffeensis infection in human monocytes with iron-transferrin. Infect Immun. 1994 Nov;62(11):4804–4810. doi: 10.1128/iai.62.11.4804-4810.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Beckman J. S., Chen J., Ischiropoulos H., Crow J. P. Oxidative chemistry of peroxynitrite. Methods Enzymol. 1994;233:229–240. doi: 10.1016/s0076-6879(94)33026-3. [DOI] [PubMed] [Google Scholar]
  12. Beckmann J. S., Ye Y. Z., Anderson P. G., Chen J., Accavitti M. A., Tarpey M. M., White C. R. Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol Chem Hoppe Seyler. 1994 Feb;375(2):81–88. doi: 10.1515/bchm3.1994.375.2.81. [DOI] [PubMed] [Google Scholar]
  13. Belenky S. N., Robbins R. A., Rubinstein I. Nitric oxide synthase inhibitors attenuate human monocyte chemotaxis in vitro. J Leukoc Biol. 1993 May;53(5):498–503. doi: 10.1002/jlb.53.5.498. [DOI] [PubMed] [Google Scholar]
  14. Ben-Efraim S., Tak C., Fieren M. J., Romijn J. C., Beckmann I., Bonta I. L. Activity of human peritoneal macrophages against a human tumor: role of tumor necrosis factor-alpha, PGE2 and nitrite, in vitro studies. Immunol Lett. 1993 Jul;37(1):27–33. doi: 10.1016/0165-2478(93)90128-o. [DOI] [PubMed] [Google Scholar]
  15. Bermudez L. E. Differential mechanisms of intracellular killing of Mycobacterium avium and Listeria monocytogenes by activated human and murine macrophages. The role of nitric oxide. Clin Exp Immunol. 1993 Feb;91(2):277–281. doi: 10.1111/j.1365-2249.1993.tb05895.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Bose M., Farnia P. Proinflammatory cytokines can significantly induce human mononuclear phagocytes to produce nitric oxide by a cell maturation-dependent process. Immunol Lett. 1995 Nov;48(1):59–64. doi: 10.1016/0165-2478(95)02444-1. [DOI] [PubMed] [Google Scholar]
  17. Bredt D. S., Snyder S. H. Nitric oxide: a physiologic messenger molecule. Annu Rev Biochem. 1994;63:175–195. doi: 10.1146/annurev.bi.63.070194.001135. [DOI] [PubMed] [Google Scholar]
  18. Bukrinsky M. I., Nottet H. S., Schmidtmayerova H., Dubrovsky L., Flanagan C. R., Mullins M. E., Lipton S. A., Gendelman H. E. Regulation of nitric oxide synthase activity in human immunodeficiency virus type 1 (HIV-1)-infected monocytes: implications for HIV-associated neurological disease. J Exp Med. 1995 Feb 1;181(2):735–745. doi: 10.1084/jem.181.2.735. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Buttery L. D., Springall D. R., Chester A. H., Evans T. J., Standfield E. N., Parums D. V., Yacoub M. H., Polak J. M. Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite. Lab Invest. 1996 Jul;75(1):77–85. [PubMed] [Google Scholar]
  20. Bö L., Dawson T. M., Wesselingh S., Mörk S., Choi S., Kong P. A., Hanley D., Trapp B. D. Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Ann Neurol. 1994 Nov;36(5):778–786. doi: 10.1002/ana.410360515. [DOI] [PubMed] [Google Scholar]
  21. Cameron M. L., Granger D. L., Weinberg J. B., Kozumbo W. J., Koren H. S. Human alveolar and peritoneal macrophages mediate fungistasis independently of L-arginine oxidation to nitrite or nitrate. Am Rev Respir Dis. 1990 Dec;142(6 Pt 1):1313–1319. doi: 10.1164/ajrccm/142.6_Pt_1.1313. [DOI] [PubMed] [Google Scholar]
  22. Chen L. Y., Mehta J. L. Further evidence of the presence of constitutive and inducible nitric oxide synthase isoforms in human platelets. J Cardiovasc Pharmacol. 1996 Jan;27(1):154–158. doi: 10.1097/00005344-199601000-00024. [DOI] [PubMed] [Google Scholar]
  23. Chu S. C., Wu H. P., Banks T. C., Eissa N. T., Moss J. Structural diversity in the 5'-untranslated region of cytokine-stimulated human inducible nitric oxide synthase mRNA. J Biol Chem. 1995 May 5;270(18):10625–10630. doi: 10.1074/jbc.270.18.10625. [DOI] [PubMed] [Google Scholar]
  24. Clancy R. M., Abramson S. B. Nitric oxide: a novel mediator of inflammation. Proc Soc Exp Biol Med. 1995 Nov;210(2):93–101. doi: 10.3181/00379727-210-43927aa. [DOI] [PubMed] [Google Scholar]
  25. Cobbs C. S., Brenman J. E., Aldape K. D., Bredt D. S., Israel M. A. Expression of nitric oxide synthase in human central nervous system tumors. Cancer Res. 1995 Feb 15;55(4):727–730. [PubMed] [Google Scholar]
  26. Condino-Neto A., Muscará M. N., Grumach A. S., Carneiro-Sampaio M. M., De Nucci G. Neutrophils and mononuclear cells from patients with chronic granulomatous disease release nitric oxide. Br J Clin Pharmacol. 1993 May;35(5):485–490. doi: 10.1111/j.1365-2125.1993.tb04174.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Condino-neto A., Muscará M. N., Bellinati-Pires R., Carneiro-Sampaio M. M., Brandão A. C., Grumach A. S., De Nucci G. Effect of therapy with recombinant human interferon-gamma on the release of nitric oxide by neutrophils and mononuclear cells from patients with chronic granulomatous disease. J Interferon Cytokine Res. 1996 May;16(5):357–364. doi: 10.1089/jir.1996.16.357. [DOI] [PubMed] [Google Scholar]
  28. Criado-Jiménez M., Rivas-Cabañero L., Martín-Oterino J. A., López-Novoa J. M., Sánchez-Rodríguez A. Nitric oxide production by mononuclear leukocytes in alcoholic cirrhosis. J Mol Med (Berl) 1995 Jan;73(1):31–33. doi: 10.1007/BF00203616. [DOI] [PubMed] [Google Scholar]
  29. De Groot C. J., Ruuls S. R., Theeuwes J. W., Dijkstra C. D., Van der Valk P. Immunocytochemical characterization of the expression of inducible and constitutive isoforms of nitric oxide synthase in demyelinating multiple sclerosis lesions. J Neuropathol Exp Neurol. 1997 Jan;56(1):10–20. doi: 10.1097/00005072-199701000-00002. [DOI] [PubMed] [Google Scholar]
  30. De Maria R., Cifone M. G., Trotta R., Rippo M. R., Festuccia C., Santoni A., Testi R. Triggering of human monocyte activation through CD69, a member of the natural killer cell gene complex family of signal transducing receptors. J Exp Med. 1994 Nov 1;180(5):1999–2004. doi: 10.1084/jem.180.5.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Denis M. Human monocytes/macrophages: NO or no NO? J Leukoc Biol. 1994 May;55(5):682–684. doi: 10.1002/jlb.55.5.682. [DOI] [PubMed] [Google Scholar]
  32. Denis M. Tumor necrosis factor and granulocyte macrophage-colony stimulating factor stimulate human macrophages to restrict growth of virulent Mycobacterium avium and to kill avirulent M. avium: killing effector mechanism depends on the generation of reactive nitrogen intermediates. J Leukoc Biol. 1991 Apr;49(4):380–387. doi: 10.1002/jlb.49.4.380. [DOI] [PubMed] [Google Scholar]
  33. Dias-Da-Motta P., Arruda V. R., Muscará M. N., Saad S. T., De Nucci G., Costa F. F., Condino-Neto A. The release of nitric oxide and superoxide anion by neutrophils and mononuclear cells from patients with sickle cell anaemia. Br J Haematol. 1996 May;93(2):333–340. doi: 10.1046/j.1365-2141.1996.4951036.x. [DOI] [PubMed] [Google Scholar]
  34. Diefenbach A., Schindler H., Donhauser N., Lorenz E., Laskay T., MacMicking J., Röllinghoff M., Gresser I., Bogdan C. Type 1 interferon (IFNalpha/beta) and type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasite. Immunity. 1998 Jan;8(1):77–87. doi: 10.1016/s1074-7613(00)80460-4. [DOI] [PubMed] [Google Scholar]
  35. Ding A. H., Nathan C. F., Stuehr D. J. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J Immunol. 1988 Oct 1;141(7):2407–2412. [PubMed] [Google Scholar]
  36. Dugas N., Vouldoukis I., Bécherel P., Arock M., Debré P., Tardieu M., Mossalayi D. M., Delfraissy J. F., Kolb J. P., Dugas B. Triggering of CD23b antigen by anti-CD23 monoclonal antibodies induces interleukin-10 production by human macrophages. Eur J Immunol. 1996 Jun;26(6):1394–1398. doi: 10.1002/eji.1830260632. [DOI] [PubMed] [Google Scholar]
  37. Dumarey C. H., Labrousse V., Rastogi N., Vargaftig B. B., Bachelet M. Selective Mycobacterium avium-induced production of nitric oxide by human monocyte-derived macrophages. J Leukoc Biol. 1994 Jul;56(1):36–40. doi: 10.1002/jlb.56.1.36. [DOI] [PubMed] [Google Scholar]
  38. Eis A. L., Brockman D. E., Myatt L. Immunolocalization of the inducible nitric oxide synthase isoform in human fetal membranes. Am J Reprod Immunol. 1997 Oct;38(4):289–294. doi: 10.1111/j.1600-0897.1997.tb00517.x. [DOI] [PubMed] [Google Scholar]
  39. Eissa N. T., Strauss A. J., Haggerty C. M., Choo E. K., Chu S. C., Moss J. Alternative splicing of human inducible nitric-oxide synthase mRNA. tissue-specific regulation and induction by cytokines. J Biol Chem. 1996 Oct 25;271(43):27184–27187. doi: 10.1074/jbc.271.43.27184. [DOI] [PubMed] [Google Scholar]
  40. Essery S. D., Saadi A. T., Twite S. J., Weir D. M., Blackwell C. C., Busuttil A. Lewis antigen expression on human monocytes and binding of pyrogenic toxins. Agents Actions. 1994 Mar;41(1-2):108–110. doi: 10.1007/BF01986408. [DOI] [PubMed] [Google Scholar]
  41. Furusu A., Miyazaki M., Abe K., Tsukasaki S., Shioshita K., Sasaki O., Miyazaki K., Ozono Y., Koji T., Harada T. Expression of endothelial and inducible nitric oxide synthase in human glomerulonephritis. Kidney Int. 1998 Jun;53(6):1760–1768. doi: 10.1046/j.1523-1755.1998.00907.x. [DOI] [PubMed] [Google Scholar]
  42. Grabowski P. S., Wright P. K., Van 't Hof R. J., Helfrich M. H., Ohshima H., Ralston S. H. Immunolocalization of inducible nitric oxide synthase in synovium and cartilage in rheumatoid arthritis and osteoarthritis. Br J Rheumatol. 1997 Jun;36(6):651–655. doi: 10.1093/rheumatology/36.6.651. [DOI] [PubMed] [Google Scholar]
  43. Granger D. L., Hibbs J. B., Jr, Perfect J. R., Durack D. T. Specific amino acid (L-arginine) requirement for the microbiostatic activity of murine macrophages. J Clin Invest. 1988 Apr;81(4):1129–1136. doi: 10.1172/JCI113427. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Green L. C., Ruiz de Luzuriaga K., Wagner D. A., Rand W., Istfan N., Young V. R., Tannenbaum S. R. Nitrate biosynthesis in man. Proc Natl Acad Sci U S A. 1981 Dec;78(12):7764–7768. doi: 10.1073/pnas.78.12.7764. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Green L. C., Wagner D. A., Glogowski J., Skipper P. L., Wishnok J. S., Tannenbaum S. R. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem. 1982 Oct;126(1):131–138. doi: 10.1016/0003-2697(82)90118-x. [DOI] [PubMed] [Google Scholar]
  46. Gross S. S., Levi R. Tetrahydrobiopterin synthesis. An absolute requirement for cytokine-induced nitric oxide generation by vascular smooth muscle. J Biol Chem. 1992 Dec 25;267(36):25722–25729. [PubMed] [Google Scholar]
  47. Gyan B., Troye-Blomberg M., Perlmann P., Björkman A. Human monocytes cultured with and without interferon-gamma inhibit Plasmodium falciparum parasite growth in vitro via secretion of reactive nitrogen intermediates. Parasite Immunol. 1994 Jul;16(7):371–375. doi: 10.1111/j.1365-3024.1994.tb00362.x. [DOI] [PubMed] [Google Scholar]
  48. Haddad I. Y., Pataki G., Hu P., Galliani C., Beckman J. S., Matalon S. Quantitation of nitrotyrosine levels in lung sections of patients and animals with acute lung injury. J Clin Invest. 1994 Dec;94(6):2407–2413. doi: 10.1172/JCI117607. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Harwix S., Andreesen R., Ferber E., Schwamberger G. Human macrophages secrete a tumoricidal activity distinct from tumour necrosis factor-alpha and reactive nitrogen intermediates. Res Immunol. 1992 Jan;143(1):89–94. doi: 10.1016/0923-2494(92)80084-x. [DOI] [PubMed] [Google Scholar]
  50. Hibbs J. B., Jr, Westenfelder C., Taintor R., Vavrin Z., Kablitz C., Baranowski R. L., Ward J. H., Menlove R. L., McMurry M. P., Kushner J. P. Evidence for cytokine-inducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy. J Clin Invest. 1992 Mar;89(3):867–877. doi: 10.1172/JCI115666. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Hooper D. C., Bagasra O., Marini J. C., Zborek A., Ohnishi S. T., Kean R., Champion J. M., Sarker A. B., Bobroski L., Farber J. L. Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: implications for the treatment of multiple sclerosis. Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2528–2533. doi: 10.1073/pnas.94.6.2528. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Hunt N. C., Goldin R. D. Nitric oxide production by monocytes in alcoholic liver disease. J Hepatol. 1992 Mar;14(2-3):146–150. doi: 10.1016/0168-8278(92)90150-n. [DOI] [PubMed] [Google Scholar]
  53. Ikeda I., Kasajima T., Ishiyama S., Shimojo T., Takeo Y., Nishikawa T., Kameoka S., Hiroe M., Mitsunaga A. Distribution of inducible nitric oxide synthase in ulcerative colitis. Am J Gastroenterol. 1997 Aug;92(8):1339–1341. [PubMed] [Google Scholar]
  54. Kashem A., Endoh M., Yano N., Yamauchi F., Nomoto Y., Sakai H. Expression of inducible-NOS in human glomerulonephritis: the possible source is infiltrating monocytes/macrophages. Kidney Int. 1996 Aug;50(2):392–399. doi: 10.1038/ki.1996.328. [DOI] [PubMed] [Google Scholar]
  55. Keller R., Keist R., Joller P., Groscurth P. Mononuclear phagocytes from human bone marrow progenitor cells; morphology, surface phenotype, and functional properties of resting and activated cells. Clin Exp Immunol. 1993 Jan;91(1):176–182. doi: 10.1111/j.1365-2249.1993.tb03375.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Kim C., Schinkel C., Fuchs D., Stadler J., Walz A., Zedler S., von Donnersmarck G. H., Faist E. Interleukin-13 effectively down-regulates the monocyte inflammatory potential during traumatic stress. Arch Surg. 1995 Dec;130(12):1330–1336. doi: 10.1001/archsurg.1995.01430120084013. [DOI] [PubMed] [Google Scholar]
  57. King J. M., Srivastava K. D., Stefano G. B., Bilfinger T. V., Bahou W. F., Magazine H. I. Human monocyte adhesion is modulated by endothelin B receptor-coupled nitric oxide release. J Immunol. 1997 Jan 15;158(2):880–886. [PubMed] [Google Scholar]
  58. Kobzik L., Bredt D. S., Lowenstein C. J., Drazen J., Gaston B., Sugarbaker D., Stamler J. S. Nitric oxide synthase in human and rat lung: immunocytochemical and histochemical localization. Am J Respir Cell Mol Biol. 1993 Oct;9(4):371–377. doi: 10.1165/ajrcmb/9.4.371. [DOI] [PubMed] [Google Scholar]
  59. Kolb J. P., Paul-Eugene N., Damais C., Yamaoka K., Drapier J. C., Dugas B. Interleukin-4 stimulates cGMP production by IFN-gamma-activated human monocytes. Involvement of the nitric oxide synthase pathway. J Biol Chem. 1994 Apr 1;269(13):9811–9816. [PubMed] [Google Scholar]
  60. Kooy N. W., Royall J. A., Ye Y. Z., Kelly D. R., Beckman J. S. Evidence for in vivo peroxynitrite production in human acute lung injury. Am J Respir Crit Care Med. 1995 Apr;151(4):1250–1254. doi: 10.1164/ajrccm/151.4.1250. [DOI] [PubMed] [Google Scholar]
  61. Kumar V., Jindal S. K., Ganguly N. K. Release of reactive oxygen and nitrogen intermediates from monocytes of patients with pulmonary tuberculosis. Scand J Clin Lab Invest. 1995 Apr;55(2):163–169. doi: 10.3109/00365519509089609. [DOI] [PubMed] [Google Scholar]
  62. Kun J. F., Mordmüller B., Lell B., Lehman L. G., Luckner D., Kremsner P. G. Polymorphism in promoter region of inducible nitric oxide synthase gene and protection against malaria. Lancet. 1998 Jan 24;351(9098):265–266. doi: 10.1016/S0140-6736(05)78273-8. [DOI] [PubMed] [Google Scholar]
  63. Laffi G., Foschi M., Masini E., Simoni A., Mugnai L., La Villa G., Barletta G., Mannaioni P. F., Gentilini P. Increased production of nitric oxide by neutrophils and monocytes from cirrhotic patients with ascites and hyperdynamic circulation. Hepatology. 1995 Dec;22(6):1666–1673. [PubMed] [Google Scholar]
  64. Lafond-Walker A., Chen C. L., Augustine S., Wu T. C., Hruban R. H., Lowenstein C. J. Inducible nitric oxide synthase expression in coronary arteries of transplanted human hearts with accelerated graft arteriosclerosis. Am J Pathol. 1997 Oct;151(4):919–925. [PMC free article] [PubMed] [Google Scholar]
  65. Lammas D. A., Stober C., Harvey C. J., Kendrick N., Panchalingam S., Kumararatne D. S. ATP-induced killing of mycobacteria by human macrophages is mediated by purinergic P2Z(P2X7) receptors. Immunity. 1997 Sep;7(3):433–444. doi: 10.1016/s1074-7613(00)80364-7. [DOI] [PubMed] [Google Scholar]
  66. Lecoanet-Henchoz S., Gauchat J. F., Aubry J. P., Graber P., Life P., Paul-Eugene N., Ferrua B., Corbi A. L., Dugas B., Plater-Zyberk C. CD23 regulates monocyte activation through a novel interaction with the adhesion molecules CD11b-CD18 and CD11c-CD18. Immunity. 1995 Jul;3(1):119–125. doi: 10.1016/1074-7613(95)90164-7. [DOI] [PubMed] [Google Scholar]
  67. Leibovich S. J., Polverini P. J., Fong T. W., Harlow L. A., Koch A. E. Production of angiogenic activity by human monocytes requires an L-arginine/nitric oxide-synthase-dependent effector mechanism. Proc Natl Acad Sci U S A. 1994 May 10;91(10):4190–4194. doi: 10.1073/pnas.91.10.4190. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Liu J., Zhao M. L., Brosnan C. F., Lee S. C. Expression of type II nitric oxide synthase in primary human astrocytes and microglia: role of IL-1beta and IL-1 receptor antagonist. J Immunol. 1996 Oct 15;157(8):3569–3576. [PubMed] [Google Scholar]
  69. Luoma J. S., Strålin P., Marklund S. L., Hiltunen T. P., Särkioja T., Ylä-Herttuala S. Expression of extracellular SOD and iNOS in macrophages and smooth muscle cells in human and rabbit atherosclerotic lesions: colocalization with epitopes characteristic of oxidized LDL and peroxynitrite-modified proteins. Arterioscler Thromb Vasc Biol. 1998 Feb;18(2):157–167. doi: 10.1161/01.atv.18.2.157. [DOI] [PubMed] [Google Scholar]
  70. López-Moratalla N., Calleja A., González A., Pérez-Mediavilla L. A., Aymerich M. S., Burrel M. A., Santiago E. Inducible nitric oxide synthase in monocytes from patients with Graves' disease. Biochem Biophys Res Commun. 1996 Sep 24;226(3):723–729. doi: 10.1006/bbrc.1996.1420. [DOI] [PubMed] [Google Scholar]
  71. MacMicking J., Xie Q. W., Nathan C. Nitric oxide and macrophage function. Annu Rev Immunol. 1997;15:323–350. doi: 10.1146/annurev.immunol.15.1.323. [DOI] [PubMed] [Google Scholar]
  72. Magazine H. I., Liu Y., Bilfinger T. V., Fricchione G. L., Stefano G. B. Morphine-induced conformational changes in human monocytes, granulocytes, and endothelial cells and in invertebrate immunocytes and microglia are mediated by nitric oxide. J Immunol. 1996 Jun 15;156(12):4845–4850. [PubMed] [Google Scholar]
  73. Majano P. L., García-Monzón C., López-Cabrera M., Lara-Pezzi E., Fernández-Ruiz E., García-Iglesias C., Borque M. J., Moreno-Otero R. Inducible nitric oxide synthase expression in chronic viral hepatitis. Evidence for a virus-induced gene upregulation. J Clin Invest. 1998 Apr 1;101(7):1343–1352. doi: 10.1172/JCI774. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Malinski T., Radomski M. W., Taha Z., Moncada S. Direct electrochemical measurement of nitric oxide released from human platelets. Biochem Biophys Res Commun. 1993 Jul 30;194(2):960–965. doi: 10.1006/bbrc.1993.1914. [DOI] [PubMed] [Google Scholar]
  75. Mannick E. E., Bravo L. E., Zarama G., Realpe J. L., Zhang X. J., Ruiz B., Fontham E. T., Mera R., Miller M. J., Correa P. Inducible nitric oxide synthase, nitrotyrosine, and apoptosis in Helicobacter pylori gastritis: effect of antibiotics and antioxidants. Cancer Res. 1996 Jul 15;56(14):3238–3243. [PubMed] [Google Scholar]
  76. Mannick J. B., Asano K., Izumi K., Kieff E., Stamler J. S. Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation. Cell. 1994 Dec 30;79(7):1137–1146. doi: 10.1016/0092-8674(94)90005-1. [DOI] [PubMed] [Google Scholar]
  77. Mannick J. B., Miao X. Q., Stamler J. S. Nitric oxide inhibits Fas-induced apoptosis. J Biol Chem. 1997 Sep 26;272(39):24125–24128. doi: 10.1074/jbc.272.39.24125. [DOI] [PubMed] [Google Scholar]
  78. Martin J. H., Edwards S. W. Changes in mechanisms of monocyte/macrophage-mediated cytotoxicity during culture. Reactive oxygen intermediates are involved in monocyte-mediated cytotoxicity, whereas reactive nitrogen intermediates are employed by macrophages in tumor cell killing. J Immunol. 1993 Apr 15;150(8 Pt 1):3478–3486. [PubMed] [Google Scholar]
  79. Martin J. H., Edwards S. W. Interferon-gamma enhances monocyte cytotoxicity via enhanced reactive oxygen intermediate production. Absence of an effect on macrophage cytotoxicity is due to failure to enhance reactive nitrogen intermediate production. Immunology. 1994 Apr;81(4):592–597. [PMC free article] [PubMed] [Google Scholar]
  80. Masini E., Mugnai L., Foschi M., Laffi G., Gentilini P., Mannaioni P. F. Changes in the production of nitric oxide and superoxide by inflammatory cells in liver cirrhosis. Int Arch Allergy Immunol. 1995 May-Jun;107(1-3):197–198. doi: 10.1159/000236975. [DOI] [PubMed] [Google Scholar]
  81. Mautino G., Paul-Eugène N., Chanez P., Vignola A. M., Kolb J. P., Bousquet J., Dugas B. Heterogeneous spontaneous and interleukin-4-induced nitric oxide production by human monocytes. J Leukoc Biol. 1994 Jul;56(1):15–20. doi: 10.1002/jlb.56.1.15. [DOI] [PubMed] [Google Scholar]
  82. McDermott C. D., Gavita S. M., Shennib H., Giaid A. Immunohistochemical localization of nitric oxide synthase and the oxidant peroxynitrite in lung transplant recipients with obliterative bronchiolitis. Transplantation. 1997 Jul 27;64(2):270–274. doi: 10.1097/00007890-199707270-00016. [DOI] [PubMed] [Google Scholar]
  83. McInnes I. B., Leung B. P., Field M., Wei X. Q., Huang F. P., Sturrock R. D., Kinninmonth A., Weidner J., Mumford R., Liew F. Y. Production of nitric oxide in the synovial membrane of rheumatoid and osteoarthritis patients. J Exp Med. 1996 Oct 1;184(4):1519–1524. doi: 10.1084/jem.184.4.1519. [DOI] [PMC free article] [PubMed] [Google Scholar]
  84. McLachlan J. A., Serkin C. D., Bakouche O. Dehydroepiandrosterone modulation of lipopolysaccharide-stimulated monocyte cytotoxicity. J Immunol. 1996 Jan 1;156(1):328–335. [PubMed] [Google Scholar]
  85. Middleton S. J., Cuthbert A. W., Shorthouse M., Hunter J. O. Nitric oxide affects mammalian distal colonic smooth muscle by tonic neural inhibition. Br J Pharmacol. 1993 Apr;108(4):974–979. doi: 10.1111/j.1476-5381.1993.tb13494.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  86. Moilanen E., Moilanen T., Knowles R., Charles I., Kadoya Y., al-Saffar N., Revell P. A., Moncada S. Nitric oxide synthase is expressed in human macrophages during foreign body inflammation. Am J Pathol. 1997 Mar;150(3):881–887. [PMC free article] [PubMed] [Google Scholar]
  87. Moncada S., Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med. 1993 Dec 30;329(27):2002–2012. doi: 10.1056/NEJM199312303292706. [DOI] [PubMed] [Google Scholar]
  88. Murray H. W., Teitelbaum R. F. L-arginine-dependent reactive nitrogen intermediates and the antimicrobial effect of activated human mononuclear phagocytes. J Infect Dis. 1992 Mar;165(3):513–517. doi: 10.1093/infdis/165.3.513. [DOI] [PubMed] [Google Scholar]
  89. Muñoz-Fernández M. A., Fernández M. A., Fresno M. Activation of human macrophages for the killing of intracellular Trypanosoma cruzi by TNF-alpha and IFN-gamma through a nitric oxide-dependent mechanism. Immunol Lett. 1992 Jun;33(1):35–40. doi: 10.1016/0165-2478(92)90090-b. [DOI] [PubMed] [Google Scholar]
  90. Myatt L., Eis A. L., Brockman D. E., Kossenjans W., Greer I., Lyall F. Inducible (type II) nitric oxide synthase in human placental villous tissue of normotensive, pre-eclamptic and intrauterine growth-restricted pregnancies. Placenta. 1997 May;18(4):261–268. doi: 10.1016/s0143-4004(97)80060-4. [DOI] [PubMed] [Google Scholar]
  91. Naotunne T. S., Karunaweera N. D., Mendis K. N., Carter R. Cytokine-mediated inactivation of malarial gametocytes is dependent on the presence of white blood cells and involves reactive nitrogen intermediates. Immunology. 1993 Apr;78(4):555–562. [PMC free article] [PubMed] [Google Scholar]
  92. Nathan C. Nitric oxide and biopterin: a study in Chiaroscuro. J Clin Invest. 1994 May;93(5):1875–1876. doi: 10.1172/JCI117176. [DOI] [PMC free article] [PubMed] [Google Scholar]
  93. Nathan C., Xie Q. W. Regulation of biosynthesis of nitric oxide. J Biol Chem. 1994 May 13;269(19):13725–13728. [PubMed] [Google Scholar]
  94. Nicholson S., Bonecini-Almeida M. da G., Lapa e Silva J. R., Nathan C., Xie Q. W., Mumford R., Weidner J. R., Calaycay J., Geng J., Boechat N. Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis. J Exp Med. 1996 May 1;183(5):2293–2302. doi: 10.1084/jem.183.5.2293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  95. Nozaki Y., Hasegawa Y., Ichiyama S., Nakashima I., Shimokata K. Mechanism of nitric oxide-dependent killing of Mycobacterium bovis BCG in human alveolar macrophages. Infect Immun. 1997 Sep;65(9):3644–3647. doi: 10.1128/iai.65.9.3644-3647.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  96. Ochoa J. B., Curti B., Peitzman A. B., Simmons R. L., Billiar T. R., Hoffman R., Rault R., Longo D. L., Urba W. J., Ochoa A. C. Increased circulating nitrogen oxides after human tumor immunotherapy: correlation with toxic hemodynamic changes. J Natl Cancer Inst. 1992 Jun 3;84(11):864–867. doi: 10.1093/jnci/84.11.864. [DOI] [PubMed] [Google Scholar]
  97. Padgett E. L., Pruett S. B. Evaluation of nitrite production by human monocyte-derived macrophages. Biochem Biophys Res Commun. 1992 Jul 31;186(2):775–781. doi: 10.1016/0006-291x(92)90813-z. [DOI] [PubMed] [Google Scholar]
  98. Paul-Eugène N., Kolb J. P., Damais C., Yamaoka K., Dugas B. Regulatory role of nitric oxide in the IL-4-induced IgE production by normal human peripheral blood mononuclear cells. Lymphokine Cytokine Res. 1994 Oct;13(5):287–293. [PubMed] [Google Scholar]
  99. Paul-Eugène N., Kolb J. P., Sarfati M., Arock M., Ouaaz F., Debré P., Mossalayi D. M., Dugas B. Ligation of CD23 activates soluble guanylate cyclase in human monocytes via an L-arginine-dependent mechanism. J Leukoc Biol. 1995 Jan;57(1):160–167. doi: 10.1002/jlb.57.1.160. [DOI] [PubMed] [Google Scholar]
  100. Paul-Eugène N., Mossalayi D., Sarfati M., Yamaoka K., Aubry J. P., Bonnefoy J. Y., Dugas B., Kolb J. P. Evidence for a role of Fc epsilon RII/CD23 in the IL-4-induced nitric oxide production by normal human mononuclear phagocytes. Cell Immunol. 1995 Jul;163(2):314–318. doi: 10.1006/cimm.1995.1132. [DOI] [PubMed] [Google Scholar]
  101. Paul-Eugène N., Pène J., Bousquet J., Dugas B. Role of cyclic nucleotides and nitric oxide in blood mononuclear cell IgE production stimulated by IL-4. Cytokine. 1995 Jan;7(1):64–69. doi: 10.1006/cyto.1995.1008. [DOI] [PubMed] [Google Scholar]
  102. Petit J. F., Phan-Bich L., Lemaire G., Martinache C., Lopez M. During their differentiation into macrophages, human monocytes acquire cytostatic activity independent of NO and TNF alpha. Res Immunol. 1993 May;144(4):277–298. doi: 10.1016/0923-2494(93)80107-a. [DOI] [PubMed] [Google Scholar]
  103. Pietraforte D., Tritarelli E., Testa U., Minetti M. gp120 HIV envelope glycoprotein increases the production of nitric oxide in human monocyte-derived macrophages. J Leukoc Biol. 1994 Feb;55(2):175–182. doi: 10.1002/jlb.55.2.175. [DOI] [PubMed] [Google Scholar]
  104. Polack B., Pernod G., Barro C., Doussière J. Role of oxygen radicals in tissue factor induction by endotoxin in blood monocytes. Haemostasis. 1997 Jul-Aug;27(4):193–200. doi: 10.1159/000217456. [DOI] [PubMed] [Google Scholar]
  105. Pérez-Mediavilla L. A., López-Zabalza M. J., Calonge M., Montuenga L., López-Moratalla N., Santiago E. Inducible nitric oxide synthase in human lymphomononuclear cells activated by synthetic peptides derived from extracellular matrix proteins. FEBS Lett. 1995 Jan 3;357(2):121–124. doi: 10.1016/0014-5793(94)01322-r. [DOI] [PubMed] [Google Scholar]
  106. Radomski M. W., Palmer R. M., Moncada S. Characterization of the L-arginine:nitric oxide pathway in human platelets. Br J Pharmacol. 1990 Oct;101(2):325–328. doi: 10.1111/j.1476-5381.1990.tb12709.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  107. Reiling N., Kröncke R., Ulmer A. J., Gerdes J., Flad H. D., Hauschildt S. Nitric oxide synthase: expression of the endothelial, Ca2+/calmodulin-dependent isoform in human B and T lymphocytes. Eur J Immunol. 1996 Mar;26(3):511–516. doi: 10.1002/eji.1830260302. [DOI] [PubMed] [Google Scholar]
  108. Reiling N., Ulmer A. J., Duchrow M., Ernst M., Flad H. D., Hauschildt S. Nitric oxide synthase: mRNA expression of different isoforms in human monocytes/macrophages. Eur J Immunol. 1994 Aug;24(8):1941–1944. doi: 10.1002/eji.1830240836. [DOI] [PubMed] [Google Scholar]
  109. Rogers N. E., Ignarro L. J. Constitutive nitric oxide synthase from cerebellum is reversibly inhibited by nitric oxide formed from L-arginine. Biochem Biophys Res Commun. 1992 Nov 30;189(1):242–249. doi: 10.1016/0006-291x(92)91550-a. [DOI] [PubMed] [Google Scholar]
  110. Rosenkranz-Weiss P., Sessa W. C., Milstien S., Kaufman S., Watson C. A., Pober J. S. Regulation of nitric oxide synthesis by proinflammatory cytokines in human umbilical vein endothelial cells. Elevations in tetrahydrobiopterin levels enhance endothelial nitric oxide synthase specific activity. J Clin Invest. 1994 May;93(5):2236–2243. doi: 10.1172/JCI117221. [DOI] [PMC free article] [PubMed] [Google Scholar]
  111. Saha D. C., Astiz M. E., Lin R. Y., Rackow E. C., Eales L. J. Monophosphoryl lipid A stimulated up-regulation of nitric oxide synthase and nitric oxide release by human monocytes in vitro. Immunopharmacology. 1997 Oct;37(2-3):175–184. doi: 10.1016/s0162-3109(97)00045-3. [DOI] [PubMed] [Google Scholar]
  112. Sakai N., Milstien S. Availability of tetrahydrobiopterin is not a factor in the inability to detect nitric oxide production by human macrophages. Biochem Biophys Res Commun. 1993 May 28;193(1):378–383. doi: 10.1006/bbrc.1993.1634. [DOI] [PubMed] [Google Scholar]
  113. Sakurai H., Kohsaka H., Liu M. F., Higashiyama H., Hirata Y., Kanno K., Saito I., Miyasaka N. Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides. J Clin Invest. 1995 Nov;96(5):2357–2363. doi: 10.1172/JCI118292. [DOI] [PMC free article] [PubMed] [Google Scholar]
  114. Salvemini D., de Nucci G., Gryglewski R. J., Vane J. R. Human neutrophils and mononuclear cells inhibit platelet aggregation by releasing a nitric oxide-like factor. Proc Natl Acad Sci U S A. 1989 Aug;86(16):6328–6332. doi: 10.1073/pnas.86.16.6328. [DOI] [PMC free article] [PubMed] [Google Scholar]
  115. Schneemann M., Schoedon G., Hofer S., Blau N., Guerrero L., Schaffner A. Nitric oxide synthase is not a constituent of the antimicrobial armature of human mononuclear phagocytes. J Infect Dis. 1993 Jun;167(6):1358–1363. doi: 10.1093/infdis/167.6.1358. [DOI] [PubMed] [Google Scholar]
  116. Schneemann M., Schoedon G., Linscheid P., Walter R., Blau N., Schaffner A. Nitrite generation in interleukin-4-treated human macrophage cultures does not involve the nitric oxide synthase pathway. J Infect Dis. 1997 Jan;175(1):130–135. doi: 10.1093/infdis/175.1.130. [DOI] [PubMed] [Google Scholar]
  117. Seitzer U., Scheel-Toellner D., Toellner K. M., Reiling N., Haas H., Galle J., Flad H. D., Gerdes J. Properties of multinucleated giant cells in a new in vitro model for human granuloma formation. J Pathol. 1997 May;182(1):99–105. doi: 10.1002/(SICI)1096-9896(199705)182:1<99::AID-PATH807>3.0.CO;2-X. [DOI] [PubMed] [Google Scholar]
  118. Sharara A. I., Perkins D. J., Misukonis M. A., Chan S. U., Dominitz J. A., Weinberg J. B. Interferon (IFN)-alpha activation of human blood mononuclear cells in vitro and in vivo for nitric oxide synthase (NOS) type 2 mRNA and protein expression: possible relationship of induced NOS2 to the anti-hepatitis C effects of IFN-alpha in vivo. J Exp Med. 1997 Nov 3;186(9):1495–1502. doi: 10.1084/jem.186.9.1495. [DOI] [PMC free article] [PubMed] [Google Scholar]
  119. Sherman M. P., Loro M. L., Wong V. Z., Tashkin D. P. Cytokine- and Pneumocystis carinii- induced L-arginine oxidation by murine and human pulmonary alveolar macrophages. J Protozool. 1991 Nov-Dec;38(6):234S–236S. [PubMed] [Google Scholar]
  120. Siedlar M., Marcinkiewicz J., Zembala M. MHC class I and class II determinants and some adhesion molecules are engaged in the regulation of nitric oxide production in vitro by human monocytes stimulated with colon carcinoma cells. Clin Immunol Immunopathol. 1995 Dec;77(3):380–384. doi: 10.1006/clin.1995.1166. [DOI] [PubMed] [Google Scholar]
  121. Singer I. I., Kawka D. W., Scott S., Weidner J. R., Mumford R. A., Riehl T. E., Stenson W. F. Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease. Gastroenterology. 1996 Oct;111(4):871–885. doi: 10.1016/s0016-5085(96)70055-0. [DOI] [PubMed] [Google Scholar]
  122. Snell J. C., Chernyshev O., Gilbert D. L., Colton C. A. Polyribonucleotides induce nitric oxide production by human monocyte-derived macrophages. J Leukoc Biol. 1997 Sep;62(3):369–373. doi: 10.1002/jlb.62.3.369. [DOI] [PubMed] [Google Scholar]
  123. St Clair E. W., Wilkinson W. E., Lang T., Sanders L., Misukonis M. A., Gilkeson G. S., Pisetsky D. S., Granger D. I., Weinberg J. B. Increased expression of blood mononuclear cell nitric oxide synthase type 2 in rheumatoid arthritis patients. J Exp Med. 1996 Sep 1;184(3):1173–1178. doi: 10.1084/jem.184.3.1173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  124. Stamler J. S., Singel D. J., Loscalzo J. Biochemistry of nitric oxide and its redox-activated forms. Science. 1992 Dec 18;258(5090):1898–1902. doi: 10.1126/science.1281928. [DOI] [PubMed] [Google Scholar]
  125. Stefano G. B., Liu Y., Goligorsky M. S. Cannabinoid receptors are coupled to nitric oxide release in invertebrate immunocytes, microglia, and human monocytes. J Biol Chem. 1996 Aug 9;271(32):19238–19242. doi: 10.1074/jbc.271.32.19238. [DOI] [PubMed] [Google Scholar]
  126. Thomsen L. L., Lawton F. G., Knowles R. G., Beesley J. E., Riveros-Moreno V., Moncada S. Nitric oxide synthase activity in human gynecological cancer. Cancer Res. 1994 Mar 1;54(5):1352–1354. [PubMed] [Google Scholar]
  127. Tracey W. R., Xue C., Klinghofer V., Barlow J., Pollock J. S., Förstermann U., Johns R. A. Immunochemical detection of inducible NO synthase in human lung. Am J Physiol. 1994 Jun;266(6 Pt 1):L722–L727. doi: 10.1152/ajplung.1994.266.6.L722. [DOI] [PubMed] [Google Scholar]
  128. Tufano M. A., Rossano F., Catalanotti P., Liguori G., Marinelli A., Baroni A., Marinelli P. Properties of Yersinia enterocolitica porins: interference with biological functions of phagocytes, nitric oxide production and selective cytokine release. Res Microbiol. 1994 May;145(4):297–307. doi: 10.1016/0923-2508(94)90185-6. [DOI] [PubMed] [Google Scholar]
  129. Tunçtan B., Okur H., Calişir C. H., Abacioğlu H., Cakici I., Kanzik I., Abacioğlu N. Comparison of nitric oxide production by monocyte/macrophages in healthy subjects and patients with active pulmonary tuberculosis. Pharmacol Res. 1998 Mar;37(3):219–226. doi: 10.1006/phrs.1997.0284. [DOI] [PubMed] [Google Scholar]
  130. Vitek M. P., Snell J., Dawson H., Colton C. A. Modulation of nitric oxide production in human macrophages by apolipoprotein-E and amyloid-beta peptide. Biochem Biophys Res Commun. 1997 Nov 17;240(2):391–394. doi: 10.1006/bbrc.1997.7408. [DOI] [PubMed] [Google Scholar]
  131. Vouldoukis I., Bécherel P. A., Riveros-Moreno V., Arock M., da Silva O., Debré P., Mazier D., Mossalayi M. D. Interleukin-10 and interleukin-4 inhibit intracellular killing of Leishmania infantum and Leishmania major by human macrophages by decreasing nitric oxide generation. Eur J Immunol. 1997 Apr;27(4):860–865. doi: 10.1002/eji.1830270409. [DOI] [PubMed] [Google Scholar]
  132. Vouldoukis I., Riveros-Moreno V., Dugas B., Ouaaz F., Bécherel P., Debré P., Moncada S., Mossalayi M. D. The killing of Leishmania major by human macrophages is mediated by nitric oxide induced after ligation of the Fc epsilon RII/CD23 surface antigen. Proc Natl Acad Sci U S A. 1995 Aug 15;92(17):7804–7808. doi: 10.1073/pnas.92.17.7804. [DOI] [PMC free article] [PubMed] [Google Scholar]
  133. Wang C. H., Liu C. Y., Lin H. C., Yu C. T., Chung K. F., Kuo H. P. Increased exhaled nitric oxide in active pulmonary tuberculosis due to inducible NO synthase upregulation in alveolar macrophages. Eur Respir J. 1998 Apr;11(4):809–815. doi: 10.1183/09031936.98.11040809. [DOI] [PubMed] [Google Scholar]
  134. Wang C. L., Su M. H., Chao T. Y., Shaio M. F., Yang K. D. When do human macrophages release nitric oxide? Variable effects of certain in vitro cultural and in vivo resident conditions. Proc Natl Sci Counc Repub China B. 1996 Jul;20(3):65–70. [PubMed] [Google Scholar]
  135. Watkins S. C., Macaulay W., Turner D., Kang R., Rubash H. E., Evans C. H. Identification of inducible nitric oxide synthase in human macrophages surrounding loosened hip prostheses. Am J Pathol. 1997 Apr;150(4):1199–1206. [PMC free article] [PubMed] [Google Scholar]
  136. Weinberg J. B., Misukonis M. A., Shami P. J., Mason S. N., Sauls D. L., Dittman W. A., Wood E. R., Smith G. K., McDonald B., Bachus K. E. Human mononuclear phagocyte inducible nitric oxide synthase (iNOS): analysis of iNOS mRNA, iNOS protein, biopterin, and nitric oxide production by blood monocytes and peritoneal macrophages. Blood. 1995 Aug 1;86(3):1184–1195. [PubMed] [Google Scholar]
  137. Weyand C. M., Wagner A. D., Björnsson J., Goronzy J. J. Correlation of the topographical arrangement and the functional pattern of tissue-infiltrating macrophages in giant cell arteritis. J Clin Invest. 1996 Oct 1;98(7):1642–1649. doi: 10.1172/JCI118959. [DOI] [PMC free article] [PubMed] [Google Scholar]
  138. Wickramasinghe S. N., Hasan R. Possible role of macrophages in the pathogenesis of ethanol-induced bone marrow damage. Br J Haematol. 1993 Apr;83(4):574–579. doi: 10.1111/j.1365-2141.1993.tb04693.x. [DOI] [PubMed] [Google Scholar]
  139. Wilcox J. N., Subramanian R. R., Sundell C. L., Tracey W. R., Pollock J. S., Harrison D. G., Marsden P. A. Expression of multiple isoforms of nitric oxide synthase in normal and atherosclerotic vessels. Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):2479–2488. doi: 10.1161/01.atv.17.11.2479. [DOI] [PubMed] [Google Scholar]
  140. Wildhirt S. M., Dudek R. R., Suzuki H., Bing R. J. Involvement of inducible nitric oxide synthase in the inflammatory process of myocardial infarction. Int J Cardiol. 1995 Jul;50(3):253–261. doi: 10.1016/0167-5273(95)02385-a. [DOI] [PubMed] [Google Scholar]
  141. Zarlingo T. J., Eis A. L., Brockman D. E., Kossenjans W., Myatt L. Comparative localization of endothelial and inducible nitric oxide synthase isoforms in haemochorial and epitheliochorial placentae. Placenta. 1997 Sep;18(7):511–520. doi: 10.1016/0143-4004(77)90004-2. [DOI] [PubMed] [Google Scholar]
  142. Zembala M., Siedlar M., Marcinkiewicz J., Pryjma J. Human monocytes are stimulated for nitric oxide release in vitro by some tumor cells but not by cytokines and lipopolysaccharide. Eur J Immunol. 1994 Feb;24(2):435–439. doi: 10.1002/eji.1830240225. [DOI] [PubMed] [Google Scholar]
  143. Zhou A., Chen Z., Rummage J. A., Jiang H., Kolosov M., Kolosova I., Stewart C. A., Leu R. W. Exogenous interferon-gamma induces endogenous synthesis of interferon-alpha and -beta by murine macrophages for induction of nitric oxide synthase. J Interferon Cytokine Res. 1995 Oct;15(10):897–904. doi: 10.1089/jir.1995.15.897. [DOI] [PubMed] [Google Scholar]
  144. Zinetti M., Fantuzzi G., Delgado R., Di Santo E., Ghezzi P., Fratelli M. Endogenous nitric oxide production by human monocytic cells regulates LPS-induced TNF production. Eur Cytokine Netw. 1995 Jan-Feb;6(1):45–48. [PubMed] [Google Scholar]
  145. ter Steege J., Buurman W., Arends J. W., Forget P. Presence of inducible nitric oxide synthase, nitrotyrosine, CD68, and CD14 in the small intestine in celiac disease. Lab Invest. 1997 Jul;77(1):29–36. [PubMed] [Google Scholar]

Articles from Molecular Medicine are provided here courtesy of The Feinstein Institute for Medical Research at North Shore LIJ

RESOURCES